8/12/2019 Contraception w 1 e 2

1/17

Safety and Efficacy ofContraceptive Methods

8/12/2019 Contraception w 1 e 2

2/17

How To Help A Patient Choose?

!"#$%& ()*"*&

+",$-% +.$#$.$-*$

8/12/2019 Contraception w 1 e 2

3/17

Satisfaction With Contraceptive Methods

/01 /02 /03 /03 405 401 406

7!

",89$:

6; 616< ;5 ;2

1?!@ !A@B!CB(D E(A!@ !A@B!CB(D

!"#$%$&'( *+,- !"(,./- 0+1"'2% 3"/.45 6/-" 7$%$48 =

8/12/2019 Contraception w 1 e 2

4/17

WHO Medical Eligibil i ty Criteria (MEC)

o (FG:$-*$ H"8$: IJG:$KG-$8 #L. *L-%."*$M,F$ J8$H& %N$ OL.K: P$"K%N ?.I"-GQ",L- ROP?S 8G-*$

3551 JM:"%$: .$IJK".K& H"8$: L- -$T $FG:$-*$U*J..$-% /%N$:G,L-

o V$*LWW$-:",L-8 #L. %N$ 8"#$ J8$ L#*L-%."*$M,F$8 "WL-I TLW$- "-: W$-

o A::.$88 *.G%$.G" #L. %N$ G-G,",L- "-: *L-,-J$:J8$ L# "KK W$%NL:8 $F"KJ"%$:

8/12/2019 Contraception w 1 e 2

5/17

MEC Categories1 Can use the method No restrictions

2 Can use the method Advantages generallyoutweigh theoretical or

proven risks

3 Should not use methodunless no other method

is appropriate

Theoretical or proven risksgenerally outweigh

advantages

4 Should not use method Unacceptable health risk

8/12/2019 Contraception w 1 e 2

6/17

>$:G*"K

*L-:G,L-8

XG.%N *L-%.LK

W$%NL:8

>(Y Y"%$IL.&

8/12/2019 Contraception w 1 e 2

7/17

United States MEC: 2010

o YJ..$-% OP? >(Y *L-%"G-8 Z 36

8/12/2019 Contraception w 1 e 2

8/17

U.S. MEC for Contraceptive Use

8/12/2019 Contraception w 1 e 2

9/17

U.S. MEC for Contraceptive Use

8/12/2019 Contraception w 1 e 2

10/17

Contraceptive Efficacy

+$.#$*% ]8$ @&MG*"K ]8$

AKK ]8$.8 G- AKK Y&*K$8C.LW YKG-G*"K @.G"K8 _ KLL`G-I L-K&

"% %N$ WL-%N8 TN$- %N$ W$%NL:

T"8 J8$: *L..$*%K& "-: *L-8G8%$-%K&

a

8/12/2019 Contraception w 1 e 2

11/17

The Pear l Indexo [JWH$. L# M.$I-"-*G$8 M$. 3

8/12/2019 Contraception w 1 e 2

12/17

Efficacy Examples+$.#$*% J8$ @&MG*"K J8$

o YL-:LW8 = 32o ?Y+

8/12/2019 Contraception w 1 e 2

13/17

Natural Family Planning

YL-%."*$M,F$ >$%NL:C"GKJ.$ V"%$

+$.#$*% ]8$ @&MG*"K ]8$

[L >$%NL: 627 627

+$.GL:G* AH8,-$-*$

!%"-:".: D"&8 >$%NL:de 27 3=7

?FJK",L- >$%NL: 47 ==7

!&WM%L%N$.W"K =7 34f=

8/12/2019 Contraception w 1 e 2

14/17

Barrier Methods

YL-%."*$M,F$ >$%NL:C"GKJ.$ V"%$

+$.#$*% ]8$ @&MG*"K ]8$

OG%N:."T"K / 7 36 7

YL-:LW8 = 7 3; 7

Y$.FG*"K Y"M RM".LJ8g-JKKGMS =17g57 4=7g317

!ML-I$ RM".LJ8g-JKKGM".LJ8S =";5'+.+(?

8/12/2019 Contraception w 1 e 2

15/17

Hormonal MethodsYL-%."*$M,F$ >$%NL:

C"GKJ.$ V"%$

+$.#$*% ]8$ @&MG*"K ]8$

YLWHG-$: PL.WL-"K +GKK8 h3 7 6 7

+.LI$8,- ?-K& +GKK8 h3 7 6 7@."-8:$.W"K +"%*N h3 7 6 7

i"IG-"K VG-I h3 7 6 7

4f>L-%N B-\$*,L- h3 7 4 7

BWMK"-%8 h3 7 h3 7

YLMM$. B]DgE[j B]! h3 7 h3 7

9/&+'/. 6"'4"- 3"/.45 :4/&%&;%< 6+'4-/;"=" >";5'+.+(?

8/12/2019 Contraception w 1 e 2

16/17

@%%+;$/&+' +A !"=-+B,;" 3"/.45 C-+A"%%$+'/.%

8/12/2019 Contraception w 1 e 2

17/17

Current Contraceptive Methods>L8% $k$*,F$

+.$F$-%8

M.$I-"-*& Z557 L#

%N$ ,W$

>"K$gC$W"K$

!%$.GKGQ",L-

B]DgB]!

BWMK"-%8

i$.& $k$*,F$

+.$F$-%8

M.$I-"-*&

l53f557 L# %N$,W$

+GKK8

B-\$*%"HK$8

+"%*N

VG-I

>L:$."%$K&

$k$*,F$

+.$F$-%8

M.$I-"-*&l63f5"K$gC$W"K$

YL-:LW

!ML-I$

DG"MN."IW

(k$*,F$

+.$F$-%8

M.$I-"-*& JM %L

6